Endpoints News
‘It is hype and bullshit’: Scientist challenges claims that pig-to-human xenotransplantation is close to realization
Steve Holtzman was awoken by a 1 a.m. call from a doctor at Duke University asking if he could put ...
Here’s the skinny on the CRISPR patent saga between the Broad Institute and the CVC group
CRISPR was first reported by Jennifer Doudna and Emmanuelle Charpentier in 2012, as an outgrowth of their work on bacterial ...
‘Exceptionally potent yet easily scalable’: Synthetic biology-based COVID vaccine could pull ahead of current frontrunners
Years ago, researchers learned that, when made with biotechnology, some viral proteins could spontaneously assemble themselves into “virus-like particles,” or ...
In a politically divided America, here’s how the biotechnology sector sees its future
[W]hat does Joe Biden’s presidency mean for biopharma? Part of that question will rest on whether Democrats can pull of ...
Chinese biopharma firms ‘well ahead’ in race to use CRISPR in humans
Contrary to what you might believe, biopharma companies in the US are not the leaders in clinical trials using gene ...
